Direct peritumoral/intratumoral dendritic cell (DC) injections are more beneficial than subcutaneous administration [18], due to increased pro-immune cytokine production and tumor CD8+ T-cell infiltration, along with decreased Treg infiltration, tumor cell proliferation via TNF-α [19] and immunosuppressive cytokines [20]. Here, TNF is linked to neoplasm.